Combination CAR-T Cell Therapy Targeting Hematological Malignancies

Clinical trial NCT03125577 · RECRUITING

Trial details

NCT number: NCT03125577
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Malignancies

Start date: 2025-08-01
Primary completion: 2028-12-31
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.